- Seroprevalence of Hepatitis C Virus Infection in North Korean Defectors Residing in Korea
-
Hong YM, Yoon KT, Park YJ, Woo HY, Heo J
- KMID: 2545546
- J Korean Med Sci.
- 2023 Aug;38(34):e270.
- doi: 10.3346/jkms.2023.38.e270
Background This study aimed to investigate the prevalence rate of hepatitis C virus (HCV) infection and identify the demographic, and sociological characteristics and changes in awareness of HCV infection by participating... -
- CITED
-
- Close
- SHARE
-
- Close
- Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
-
Jun YK, Koh SJ, Myung DS, Park SH, Ooi CJ, Sood A, Im JP
- KMID: 2544758
- Intest Res.
- 2023 Jul;21(3):353-362.
- doi: 10.5217/ir.2023.00013
Background/Aims: Infectious complications are major concerns when treating patients with inflammatory bowel disease (IBD). This study evaluated clinical differences across countries/regions in the management of infectious diseases in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Experimental model and novel therapeutic targets for non-alcoholic fatty liver disease development
-
Jin Y, Heo KS
- KMID: 2544132
- Korean J Physiol Pharmacol.
- 2023 Jul;27(4):299-310.
- doi: 10.4196/kjpp.2023.27.4.299
Non-alcoholic fatty liver disease (NAFLD) is a complex disorder characterized by the accumulation of fat in the liver in the absence of excessive alcohol consumption. It is one of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study
-
Jang H, Yu SJ, Lee HG, Kim TM, Lee YB, Cho EJ, Lee JH, Yoon JH, Kim YJ
- KMID: 2544475
- J Korean Med Sci.
- 2023 Jul;38(28):e216.
- doi: 10.3346/jkms.2023.38.e216
Background: Rituximab occasionally induces reactivation of hepatitis B virus (HBV) in patients with resolved HBV, at times with fatal consequences. The optimal duration of prophylactic antiviral therapy in this situation... -
- CITED
-
- Close
- SHARE
-
- Close
- Correspondence on Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
-
Oh JH, Sinn DH
- KMID: 2544001
- Clin Mol Hepatol.
- 2023 Jul;29(3):820-820.
- doi: 10.3350/cmh.2023.0135
-
- CITED
-
- Close
- SHARE
-
- Close
- Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
-
Park J, Chung SW, Lee YB, Shin H, Hur MH, Cho H, Park MK, Youk J, Lee JY, Lee JO, Yu SJ, Kim YJ, Yoon JH, Kim TM, Lee JH
- KMID: 2543995
- Clin Mol Hepatol.
- 2023 Jul;29(3):794-809.
- doi: 10.3350/cmh.2023.0057
Background/Aims: Chronic hepatitis B (CHB) is a risk factor for non-Hodgkin lymphoma (NHL). Our recent study suggested that antiviral treatment may reduce the incidence of NHL in CHB patients. This... -
- CITED
-
- Close
- SHARE
-
- Close
- Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study
-
Lee CH, Choi GH, Choi HY, Han S, Jang ES, Chon YE, Chang Y, Kim KA, Kim DY, Yim HJ, Kim HL, Jeong SH, Kim IH
- KMID: 2543994
- Clin Mol Hepatol.
- 2023 Jul;29(3):779-793.
- doi: 10.3350/cmh.2023.0110
Background/Aims: To eliminate hepatitis B virus (HBV) and hepatitis C virus (HCV) according to the World Health Organization (WHO) criteria in 2021, this study investigated the national core indicators representing... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients
-
Wu X, Xu X, Zhou J, Sun Y, Ding H, Xie W, Chen G, Ma A, Piao H, Wang B, Chen S, Meng T, Ou X, Yang HI, Jia J, Kong Y, You H
- KMID: 2543992
- Clin Mol Hepatol.
- 2023 Jul;29(3):747-762.
- doi: 10.3350/cmh.2023.0121
Background/Aims: Existing hepatocellular carcinoma (HCC) prediction models are derived mainly from pretreatment or early on-treatment parameters. We reassessed the dynamic changes in the performance of 17 HCC models in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
-
Emiroglu HH
- KMID: 2543997
- Clin Mol Hepatol.
- 2023 Jul;29(3):812-812.
- doi: 10.3350/cmh.2023.0132
-
- CITED
-
- Close
- SHARE
-
- Close
- KASL clinical practice guidelines for management of autoimmune hepatitis 2022
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 2543981
- Clin Mol Hepatol.
- 2023 Jul;29(3):542-592.
- doi: 10.3350/cmh.2023.0087
-
- CITED
-
- Close
- SHARE
-
- Close
- Acute hepatitis C virus infection: clinical update and remaining challenges
-
Liu CH, Kao JH
- KMID: 2543984
- Clin Mol Hepatol.
- 2023 Jul;29(3):623-642.
- doi: 10.3350/cmh.2022.0349
Acute hepatitis C virus (HCV) infection is a global health concern with substantial geographical variation in the incidence rate. People who have received unsafe medical procedures, used injection drugs, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
-
Lin CL, Kao JH
- KMID: 2543983
- Clin Mol Hepatol.
- 2023 Jul;29(3):605-622.
- doi: 10.3350/cmh.2022.0342
Hepatitis B virus (HBV) is responsible for more than 50% of hepatocellular carcinoma (HCC) in HBV hyperendemic areas, such as the Asia-Pacific region. Several hepatitis B viral factors are involved... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysis
-
Giri S, Agrawal D, Afzalpurkar S, Kasturi S, Gopan A, Sundaram S, Kale A
- KMID: 2544762
- Intest Res.
- 2023 Jul;21(3):392-405.
- doi: 10.5217/ir.2022.00094
Background/Aims: The data on the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in patients with inflammatory bowel disease (IBD) are conflicting. The present systematic review... -
- CITED
-
- Close
- SHARE
-
- Close
- Experimental infection of a porcine kidney cell line with hepatitis A virus
-
Kim DH, Kim DY, Kim JH, Lim KB, Lee JB, Park SY, Song CS, Lee SW, Choi IS
- KMID: 2543762
- Korean J Vet Res.
- 2023 Jun;63(2):e15.
- doi: 10.14405/kjvr.20230019
The hepatitis A virus (HAV) induces severe acute liver injury and is adapted to human and monkey cell lines but not other cells. In this study, the HAV was inoculated... -
- CITED
-
- Close
- SHARE
-
- Close
- A Usefulness of Serologic Screening of Measles and Hepatitis a for Healthcare Workers in a Tertiary Care Hospital
-
Hong HK, An HA, kim MJ, Kim EM, Kim T, Shin HB, Han SH
- KMID: 2543141
- Korean J healthc assoc Infect Control Prev.
- 2023 Jun;28(1):106-112.
- doi: 10.14192/kjicp.2023.28.1.106
Background: It is essential to know the immunity status of healthcare workers (HCWs) against the hepatitis A virus (HAV) and measles due to the likelihood of exposure on duty. Immune... -
- CITED
-
- Close
- SHARE
-
- Close
- The diagnostic significance of hepatitis C virus antibody levels for chronic hepatitis C virus infection
-
Kang JG, Jang MK, Kim JH, Jung JH, Park JW, Kim SE, Park SH, Lee MS, Suk KT, Kim DJ, Kim HS
- KMID: 2541923
- Korean J Intern Med.
- 2023 May;38(3):362-371.
- doi: 10.3904/kjim.2022.350
Background/Aims: Although anti-hepatitis C virus (HCV) assay is widely used to screen for HCV infection, it has a high false-positive (FP) rate in low-risk populations. We investigated the accuracy of... -
- CITED
-
- Close
- SHARE
-
- Close
- Comorbidities and the use of comedications among patients with chronic hepatitis C in Korea: A nationwide cross-sectional study
-
Kwon KM, Shim JJ, Kim GA, Kim BO, Han H, Ahn HJ
- KMID: 2541921
- Korean J Intern Med.
- 2023 May;38(3):338-348.
- doi: 10.3904/kjim.2022.215
Background/Aims: Chronic hepatitis C (CHC) is the second leading cause of liver-related mortality and is more prevalent in the elderly population in Korea. Decisions to initiate treatment and selection of... -
- CITED
-
- Close
- SHARE
-
- Close
- Estimated impact of the national hepatitis B immunization program on acute viral hepatitis B among adolescents in Republic of Korea
-
Chae C, Tak S
- KMID: 2542100
- Osong Public Health Res Perspect.
- 2023 Apr;14(2):138-145.
- doi: 10.24171/j.phrp.2022.0321
Objectives: We aimed to estimate the impact of the national hepatitis B immunization program on the incidence of acute hepatitis B infection among adolescents in South Korea. Methods: We estimated the... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term outcomes of liver transplantation using grafts from donors with active hepatitis B virus replication: a multicenter cohort study
-
Gang S, Choi Y, Lee 2 B, Yoon KC, Hong Sy, Suh S, Han ES, Hong SK, Lee HW, Cho JY, Yi Nj, Lee KW, Suh KS
- KMID: 2541144
- Ann Surg Treat Res.
- 2023 Apr;104(4):183-194.
- doi: 10.4174/astr.2023.104.4.183
Purpose: Liver grafts from donors with HBV infection contributed to expanding the donor pool under the hepatitis B immunoglobulin and antiviral agents (nucleos(t)ide analogues) in the HBV-endemic area. We report... -
- CITED
-
- Close
- SHARE
-
- Close
- Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
-
Oh JH, Sinn DH
- KMID: 2541419
- Clin Mol Hepatol.
- 2023 Apr;29(2):367-370.
- doi: 10.3350/cmh.2023.0054
-
- CITED
-
- Close
- SHARE
-
- Close
